HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch

By AJMC · Apr 30, 2026 · via AJMC

This is an aggregated industry headline. Read the full story at AJMC

Tags
policyformat:headlineheadlineAJMC
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from Policy
All Policy →
Purdue Pharma’s Dissolution Approved, Closing Chapter in OxyContin Legal Case
PolicyBriefing
A judge approved Purdue Pharma’s criminal sentence, clearing the way for the company’s dissolution after years…
May 1, 2026
Supreme Court questions how far generics makers can go with 'skinny label' drugs
PolicyEndpoints News ↗
WASHINGTON — Supreme Court justices gave a few hints about how they intend to rule in a divisive case for the …
Apr 30, 2026
STAT+: FDA wants to exclude weight loss drugs from a compounding list
PolicySTAT News ↗
FDA moves to remove semaglutide, tirzepatide, and liraglutide from its 503B compounding list, saying there's n…
Apr 30, 2026